Drug intelligence / Profile preview

hypoxic NK cells-derived exosomes

Development stage
Preclinical
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
Administration
Intravenous, Intratumoral
01

Overview

Exosomes derived from natural killer (NK) cells cultured under hypoxic conditions are nanoscale extracellular vesicles that carry a range of bioactive molecules, including cytotoxic proteins (such as perforin, granzymes A and B, granulysin), death ligands (Fas ligand), and regulatory microRNAs. Hypoxia enhances both the production and antitumor activity of these exosomes. These vesicles can selectively target tumor cells—inducing apoptosis via caspase-dependent and independent pathways—while sparing normal healthy cells. Mechanistically, they deliver cytotoxic payloads that disrupt tumor cell membranes or trigger programmed cell death through mitochondrial and endoplasmic reticulum stress pathways. Hypoxic preconditioning of NK cells is reported to further boost the yield and potency of their secreted exosomes for potential use in cancer immunotherapy[2][4][5].

Other names
hypoxia-induced NK cell exosomeshypoxic natural killer cell-derived extracellular vesicleshypoxic NK-EVs
02

Targets

Mitochondrial apoptosis machineryNKG2D (Natural killer group 2 member D receptor)

Beyond the preview

Go deeper on hypoxic NK cells-derived exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hypoxic NK cells-derived exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call